Bile Acid Malabsorption Deactivates Pregnane X Receptor in Patients with Crohn’s Disease
- 1 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 19 (6) , 1278-1284
Abstract
Background. Recent studies have suggested that the downregulation of pregnane X receptor (PXR) may contribute to the susceptibility and exacerbation of Crohn’sKeywords
This publication has 30 references indexed in Scilit:
- Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel DiseasePLOS ONE, 2011
- Cholesterol 25-hydroxylation activity of CYP3AJournal of Lipid Research, 2011
- 4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humansBritish Journal of Clinical Pharmacology, 2011
- Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Highly sensitive and specific analysis of sterol profiles in biological samples by HPLC–ESI–MS/MSThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Adjunctive Antibiotic Therapy with Rifaximin May Help Reduce Crohn’s Disease ActivityDigestive Diseases and Sciences, 2010
- The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolismNuclear Receptor Signaling, 2009
- Mutual repression between steroid and xenobiotic receptor and NF- B signaling pathways links xenobiotic metabolism and inflammationJournal of Clinical Investigation, 2006
- Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodeneChemical Research in Toxicology, 1990